A detailed history of Kendall Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Kendall Capital Management holds 13,100 shares of PFE stock, worth $372,826. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,100
Previous 33,176 60.51%
Holding current value
$372,826
Previous $920,000 60.22%
% of portfolio
0.12%
Previous 0.33%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $507,119 - $594,249
-20,076 Reduced 60.51%
13,100 $366,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $387,961 - $445,504
-14,985 Reduced 31.11%
33,176 $920,000
Q4 2023

Jan 26, 2024

SELL
$26.13 - $33.94 $153,121 - $198,888
-5,860 Reduced 10.85%
48,161 $1.39 Million
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $150,502 - $175,921
4,690 Added 9.51%
54,021 $1.79 Million
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $54,541 - $63,102
-1,510 Reduced 2.97%
49,331 $1.81 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $107,022 - $139,327
2,717 Added 5.65%
50,841 $2.07 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $215,263 - $281,002
5,156 Added 12.0%
48,124 $2.47 Million
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $193,025 - $235,635
4,411 Added 11.44%
42,968 $1.88 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $238,885 - $283,242
5,134 Added 15.36%
38,557 $2.02 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $47,580 - $58,957
1,040 Added 3.21%
33,423 $1.73 Million
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $2,066 - $3,062
-50 Reduced 0.15%
32,383 $1.91 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $1,216 - $1,563
-31 Reduced 0.1%
32,433 $1.4 Million
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $33,037 - $37,425
-920 Reduced 2.76%
32,464 $1.27 Million
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $6,698 - $7,554
-200 Reduced 0.6%
33,384 $1.21 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $5,020 - $6,384
-150 Reduced 0.44%
33,584 $1.24 Million
Q3 2020

Oct 22, 2020

SELL
$31.75 - $37.25 $10,763 - $12,627
-339 Reduced 0.99%
33,734 $1.24 Million
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $41,565 - $50,425
-1,380 Reduced 3.89%
34,073 $1.11 Million
Q1 2020

Apr 27, 2020

SELL
$27.03 - $38.62 $85,171 - $121,691
-3,151 Reduced 8.16%
35,453 $1.16 Million
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $64,358 - $73,038
1,955 Added 5.33%
38,604 $1.51 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $31,677 - $41,076
975 Added 2.73%
36,649 $1.32 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $54,730 - $61,449
-1,480 Reduced 3.98%
35,674 $1.55 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $2,062 - $2,266
55 Added 0.15%
37,154 $1.58 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $24,774 - $28,245
644 Added 1.77%
37,099 $1.62 Million
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $66,320 - $80,442
-1,924 Reduced 5.01%
36,455 $1.61 Million
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $219,976 - $234,517
6,670 Added 21.04%
38,379 $1.39 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $98,601 - $114,391
3,090 Added 10.8%
31,709 $1.13 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $951,867 - $1.01 Million
28,619
28,619 $1.04 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.